Who’s afraid of superbugs?
While everyone is focused on the current pandemic, how can we take actions now to reduce the threat of antibiotic resistance? More
OPTIMISE trial demonstrates safety of deprescribing for older adults
Clinicians may avoid deprescribing a blood pressure medication because they fear that patients' blood pressure will rise dangerously. For those clinicians, the new OPTIMISE trial results may put their mind at ease. More
Cancer drug approvals with new surrogate endpoints are common and concerning
How is the FDA measuring success when it comes to approval for new cancer drugs? More
How retail pharmacy policies drive overprescribing
A recent New York Times investigation revealed that retail pharmacies are pressuring pharmacists to fill prescriptions at an unsafe pace, leading to overprescribing and medication errors. More
Many older adults and caregivers unaware of drug risks, survey finds
Despite the prevalence of multiple medication use, a significant proportion of both older adults and caregivers were unaware that older adults should avoid certain medications. More
Overtreatment of diabetes leads to thousands of hospitalizations each year
A recent study finds that overtreatment of older adults for Type 2 diabetes is common, harmful, and preventable. More
One in twenty patients exposed to preventable harm, new analysis finds
Health care providers still have a long way to go when it comes to reducing preventable harm, especially harm from medications. More
Antibiotics and Anticholinergics: Not always as safe as they seem
Overuse of antibiotics and some over-the-counter medications can have serious consequences, especially for older patients. More
The psychiatric “prescribing cascade”: A patient story
Although medication overload is particularly prevalent in older adults, younger people are not immune to harm from overprescribing, particularly when it comes to drugs for psychiatric conditions. Here is one person's story of harm from the psychiatric drug prescribing cascade. More
Does the benefit of off-label Gabapentinoid use outweigh the harms?
Gabapentinoids like Neurontin and Lyrica are often prescribed for off-label uses. But does the evidence support this treatment? More